Kieffer Tara Lynn
SEC insider (Form 3/4/5 filer). CIK 0001834835. Chief Product Strategy Officer at ENANTA PHARMACEUTICALS INC (ENTA). 11 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2026. Located in WATERTOWN, MA.
Companies Kieffer Tara Lynn has filed insider reports for
- ENANTA PHARMACEUTICALS INC (ENTA): Officer, Chief Product Strategy Officer
Kieffer Tara Lynn
CIK: 0001834835
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENANTA PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Feb 12, 2026ENTA
ENANTA PHARMACEUTICALS INC
AwardDirect1.6K shares- - Feb 12, 2026ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect3.3K shares at avg. $14.25$46K - Feb 12, 2026ENTA
ENANTA PHARMACEUTICALS INC
AwardDirect5K shares- - Dec 5, 2025ENTA
ENANTA PHARMACEUTICALS INC
SaleDirect2.1K shares at avg. $14.23$30K - Dec 1, 2025ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect753 shares at avg. $14.12$11K - Nov 25, 2025ENTA
ENANTA PHARMACEUTICALS INC
AwardDirectStock Option (right to buy)
100K shares- - Feb 12, 2025ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect3.3K shares at avg. $5.59$19K - Feb 12, 2025ENTA
ENANTA PHARMACEUTICALS INC
AwardDirect7.5K shares- - Dec 6, 2024ENTA
ENANTA PHARMACEUTICALS INC
SaleDirect2.3K shares at avg. $8.06$18K - Dec 1, 2024ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect753 shares at avg. $8.60$6K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | Award | 1,575 | - | $0 | Direct |
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 3,257 | $14.25 | $46,412 | Direct |
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | Award | 4,987 | - | $0 | Direct |
| Dec 5, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Sale | 2,106 | $14.23 | $29,968 | Direct |
| Dec 1, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 753 | $14.12 | $10,632 | Direct |
| Nov 25, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Award Stock Option (right to buy) | 100,000 | - | - | Direct |
| Feb 12, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 3,326 | $5.59 | $18,592 | Direct |
| Feb 12, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Award | 7,500 | - | - | Direct |
| Dec 6, 2024 | ENTA ENANTA PHARMACEUTICALS INC | Sale | 2,283 | $8.06 | $18,401 | Direct |
| Dec 1, 2024 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 753 | $8.60 | $6,476 | Direct |
1-10 of 11 transactions